DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations - Figure 2
收藏Figshare2016-02-23 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_DDX3X_Induces_Primary_EGFR_TKI_Resistance_Based_on_Intratumor_Heterogeneity_in_Lung_Cancer_Cells_Harboring_EGFR_Activating_Mutations_Figure_2_/1218043
下载链接
链接失效反馈官方服务：
资源简介：
A. MTT assay of parental PC9 cells and A-1 cells. Cancer cells were treated with the indicated concentration of erlotinib for 48 h. Samples were prepared in triplicate. Data are presented as the mean ± SD. B. MTT assay of parental PC9 cells, A-1 cells, and A-1 cells with knockdown of DDX3X. Cancer cells were treated with the indicated concentration of erlotinib for 48 h. Samples were prepared in triplicate. Data are presented as the mean ± SD. C. Flow cytometry analysis of cancer cells treated with 20 nM erlotinib for 72 h.
创建时间：
2016-02-23
